EU Clinical Trial 2018-003537-15

Different dosing of Tranexamic Acid in patients undergoing elective total hip or knee arthroplasty. A randomized, controlled, double-blinded clinical trial.  Feb 18, 2019

Main objective of the trial: To compare the efficacy of two different dosing regimens of intravenous Tranexamic Acid during total hip or knee arthroplasty by assessing the total perioperative blood loss from start of surgery until 24 hours after end of surgery.

Parties

Sponsors
Countries
AT
Keywords
Cyklokapron 100 mg/ml Injektionslösung Hip injury Knee injury TRANEXAMIC ACID

JSON preview

Similar records

Title

Source:  EMA Last updated:  May 30, 2019

From ClinicalTrialsRegister.eu, a database of the European Medicines Agency. This record may not reflect the most current and accurate data available from the EMA.